Roche expects earnings growth

Categories: Prescription Drugs | Posted On:

According to Reuters via Pharmalot, Roche Pharmaceuticals is

expected to post a 33 percent increase in full-year net profit for 2006 to 9.11 billion Swiss francs ($7.33 billion), according to the average of a Reuters poll of 15 analysts. Sales are seen up 17 percent at 41.65 billion francs, with drugs sales 21 percent higher at 32.94 billion francs.

A strong demand this winter for Roche’s flu vaccine Tamiflu is one reason for the higher-than-expected earnings.

eDrugSearch - save on medication costs and get free drug coupons

About Cary Byrd

eDrugSearch founder, Cary Byrd, has been called an “e-health innovator” by MarketIntellNow, interviewed by top pharmaceutical industry journalists, invited to Matthew Holt’s Health 2.0 Conference and a Consumer Report's health summit, and highlighted on numerous health blogs. - Search. Compare. Save.

Leave a Reply

Join Our Free Newsletter

Please enter email id

Get a weekly dose of money-saving tips on your medications, drug side effects alerts, drug interaction warnings, free prescription coupons, late-breaking safety information and much, much more!

Share via
Copy link